A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma

NCT01730222 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: cisplatin
DRUG: capecitabine
DRUG: gemcitabine
DRUG: nab-paclitaxel

Sponsor

IRCCS San Raffaele